Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge Test
Trial details
- Registry ID
- NCT05282797
- Drugs studied
- ANEB-001
TrialRedline tracks 1 clinical trial sponsored by Anebulo Pharmaceuticals: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of CB1 Antagonist ANEB-001 in a THC Challenge TestNCT05282797 | ANEB-001 | Completed | 2023-08-26Actual |
Names as written in the registry records.